PetDx

5 articles about PetDx

• Dogs Should Be Screened for Cancer Beginning at Age 7, as Early as Age 4 for Certain Breeds, PetDx Study Shows

  2/1/2023

  PetDx® – The Liquid Biopsy Company for Pets™ published a study describing the optimal age to begin cancer screening for dogs in PLOS ONE, a peer-reviewed open-access scientific journal from the Public Library of Science.

• PetDx Appoints Alejandro Bernal as its New President and Chief Executive Officer

  1/24/2023

  PetDx® – The Liquid Biopsy Company for Pets™ announced that Alejandro Bernal, DVM, MS, MBA, has been appointed as its new President and Chief Executive Officer.

• OncoK9 Liquid Biopsy Test Can Enhance Cancer Monitoring in Dogs, New Results Show

  1/16/2023

  PetDx® – The Liquid Biopsy Company for Pets™ has released a white paper demonstrating that OncoK9®, its pioneering multi-cancer early detection test for dogs, can enhance cancer monitoring in canine patients with a simple blood draw.

• PetDx to Present at Stifel 2022 Jaws & Paws Conference

  5/27/2022

  PetDx® – The Liquid Biopsy Company for Pets™ is participating in the Stifel 2022 Jaws & Paws Conference taking place in New York City on Wednesday, June 1, 2022.

• PetDx and IDEXX Expand Access to OncoK9, the Cancer Liquid Biopsy Test for Dogs

  1/13/2022

  PetDx® announced a collaboration with IDEXX Laboratories, Inc., a global leader in pet healthcare innovation, to significantly broaden access to canine cancer liquid biopsy testing.